BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 32663354)

  • 21. Nomogram for predicting post-therapy recurrence in BCLC A/B hepatocellular carcinoma with Child-Pugh B cirrhosis.
    Qiao W; Sheng S; Xiong Y; Han M; Jin R; Hu C
    Front Immunol; 2024; 15():1369988. PubMed ID: 38799452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomograms incorporating hsa_circ_0029325 highly expressed in exosomes of hepatocellular carcinoma predict the postoperative outcomes.
    Yin KL; Sun T; Duan YX; Ye WT; Ming Li ; Liao R
    Discov Oncol; 2024 Jun; 15(1):212. PubMed ID: 38836972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
    Liang X; Bu J; Jiang Y; Zhu S; Ye Q; Deng Y; Lu W; Liu Q
    Int J Hyperthermia; 2024; 41(1):2355279. PubMed ID: 38767372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients.
    Liang X; Liangliang X; Peng W; Tao Y; Jinfu Z; Ming Z; Mingqing X
    Sci Rep; 2021 Jul; 11(1):14624. PubMed ID: 34272447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic MRI features to predict postresection survivals for very early to intermediate stage hepatocellular carcinoma.
    Jiang H; Qin Y; Wei H; Zheng T; Yang T; Wu Y; Ding C; Chernyak V; Ronot M; Fowler KJ; Chen W; Bashir MR; Song B
    Eur Radiol; 2024 May; 34(5):3163-3182. PubMed ID: 37870624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study.
    Wei H; Fu F; Jiang H; Wu Y; Qin Y; Wei H; Yang T; Wang M; Song B
    Eur Radiol; 2023 Nov; 33(11):7631-7645. PubMed ID: 37191923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Actual 10-Year Survival After Hepatectomy of HBV-Related Hepatocellular Carcinoma: a Multicenter Study.
    Li ZL; Yan WT; Zhang J; Zhao YJ; Lau WY; Mao XH; Zeng YY; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Wu H; Li C; Wang MD; Wu MC; Shen F; Yang T
    J Gastrointest Surg; 2019 Feb; 23(2):288-296. PubMed ID: 30334177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B Virus DNA-Level Change is Associated With Tumor Recurrence in Patients With Resected Hepatitis B Virus Hepatocellular Carcinoma.
    Cho WT; Yoo T; Lee JM; Lee JW; Kim H; Lee JS; Han SH
    J Surg Res; 2024 Mar; 295():231-239. PubMed ID: 38041902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
    Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
    Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and External Validation of a Nomogram Including Body Composition Parameters for Predicting Early Recurrence of Hepatocellular Carcinoma After Hepatectomy.
    Shi S; Zhao YX; Fan JL; Chang LY; Yu DX
    Acad Radiol; 2023 Dec; 30(12):2940-2953. PubMed ID: 37798207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DGPRI, a new liver fibrosis assessment index, predicts recurrence of AFP-negative hepatocellular carcinoma after hepatic resection: a single-center retrospective study.
    Zhang B; Xue J; Xu B; Chang J; Li X; Huang Z; Zhao H; Cai J
    Sci Rep; 2024 May; 14(1):10726. PubMed ID: 38730095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of severity in the grading of microvascular invasion with long-term oncological prognosis after liver resection for early-stage hepatocellular carcinoma: a multicenter retrospective cohort study from a hepatitis B virus-endemic area.
    Xu XF; Diao YK; Zeng YY; Li C; Li FW; Sun LY; Wu H; Lin KY; Yao LQ; Wang MD; Zhang CW; Lau WY; Shen F; Yang T
    Int J Surg; 2023 Apr; 109(4):841-849. PubMed ID: 36974673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ABO blood group on postoperative overall survival and recurrence-free survival rate in patients with hepatocellular carcinoma after hepatectomy: a multi-center retrospective cohort study.
    Bahardoust M; Dehkharghani MZ; Ebrahimi P; Najafirashed M; Mousavi S; Haghmoradi M; Khaleghian M; Tizmaghz A
    BMC Surg; 2023 Oct; 23(1):324. PubMed ID: 37875876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of Futile Liver Resection for Patients with Barcelona Clinic Liver Cancer Stage B/C Hepatocellular Carcinoma.
    Li C; Shen JY; Zhang XY; Peng W; Wen TF; Yang JY; Yan LN
    J Gastrointest Surg; 2018 Mar; 22(3):496-502. PubMed ID: 29119530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis as a predictor of early tumor recurrence after resection in patients with hepatoma.
    Yen YH; Kuo FY; Eng HL; Liu YW; Yong CC; Li WF; Wang CC; Lin CY
    PLoS One; 2023; 18(11):e0292144. PubMed ID: 37972101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of nomogram to predict overall survival and disease-free survival after surgical resection in elderly patients with hepatocellular carcinoma.
    Tian Y; Wang Y; Wen N; Lin Y; Liu G; Li B
    Front Oncol; 2024; 14():1395740. PubMed ID: 38854717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting overall survival and disease-free survival after surgery for hepatocellular carcinoma: a nomogram-based prognostic model-a Western European multicenter study.
    Masuda Y; Yeo MHX; Burdio F; Sanchez-Velazquez P; Perez-Xaus M; Pelegrina A; Koh YX; Di Martino M; Goh BKP; Tan EK; Teo JY; Romano F; Famularo S; Ferrari C; Griseri G; Piardi T; Sommacale D; Gianotti L; Molfino S; Baiocchi G; Ielpo B
    Updates Surg; 2024 Jan; 76(1):57-69. PubMed ID: 37839048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic nutritional index and tumor pathological characteristics predict the prognosis of elderly patients with early-stage hepatocellular carcinoma after surgery.
    Hu Y; Cai Y; Ma W; Hu H; Gu H; Jin Y; Li F
    Biosci Trends; 2023 Nov; 17(5):369-380. PubMed ID: 37813644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Surveillance in Chronic Hepatitis B Patients on Long-Term Outcomes After Curative Liver Resection for Hepatocellular Carcinoma.
    Li ZL; Wu H; Wei YP; Zhong Q; Song JC; Yu JJ; Li C; Wang MD; Xu XF; Li JD; Han J; Xing H; Lau WY; Wu MC; Shen F; Yang T
    J Gastrointest Surg; 2020 Sep; 24(9):1987-1995. PubMed ID: 31388886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of Hepatocellular Carcinoma Patients with High Risk of Early Recurrence After Radical Hepatectomy Using a Nomogram Model Based on the γ-Glutamyl Transpeptidase-to-Albumin Ratio.
    Pang S; Shi Y; Xu D; Sun Z; Chen Y; Yang Y; Zhao X; Si-Ma H; Yang N
    J Gastrointest Surg; 2022 Aug; 26(8):1-9. PubMed ID: 35508683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.